Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis. (Q54269263)

27 May 2018

title

Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis. (English)

1 reference

27 May 2018

main subject

hepatocellular carcinoma

1 reference

1 reference

Xinyu Qiu

1

1 reference

27 May 2018

Jianyong Zheng

2

1 reference

27 May 2018

Xiaodong Guo

3

1 reference

27 May 2018

Xingchun Gao

4

1 reference

27 May 2018

Hui Liu

5

1 reference

27 May 2018

Yanyang Tu

6

1 reference

27 May 2018

Yongsheng Zhang

7

1 reference

27 May 2018

publication date

11 March 2013

1 reference

27 May 2018

Molecular and Cellular Biochemistry

published in

1 reference

27 May 2018

volume

378

1 reference

27 May 2018

issue

1-2

1 reference

27 May 2018

page(s)

99-106

1 reference

27 May 2018

Global cancer statistics, 2002

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Regulation of cytokine signaling by SOCS family molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

The SOCS box: a tale of destruction and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

SOCS: role in inflammation, allergy and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Differential roles of SOCS family members in EpoR signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

The nuclear localization of SOCS6 requires the N-terminal region and negatively regulates Stat3 protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Identification of suppressor of cytokine signalling (SOCS) 6, 7, 9 and CISH in rainbow trout Oncorhynchus mykiss and analysis of their expression in relation to other known trout SOCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Suppressor of cytokine signaling 6 (SOCS6) promotes mitochondrial fission via regulating DRP1 translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Favorable prognostic value of SOCS2 and IGF-I in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Evolution of the androgen receptor pathway during progression of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Suppressor of cytokine signalling gene expression is elevated in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues

21 January 2018

1 reference

12 December 2020

Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array

1 reference

12 December 2020

Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis

1 reference

12 December 2020

Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma

1 reference

12 December 2020

The endogenous interferon system in anal squamous epithelial lesions with different grades from HIV-positive individuals

1 reference

12 December 2020

10.1007/S11010-013-1599-5

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018